Simtra BioPharma Solutions Welcomes New Chief Commercial Officer
Simtra BioPharma Solutions, a prominent contract development and manufacturing organization focused on sterile injectables, is pleased to announce that Dr. Mike Schaefers has been appointed as the new Chief Commercial Officer and Head of Business Development. In this vital position, Dr. Schaefers will oversee global commercial operations, aiming to drive business growth, strengthen customer relationships, and lead initiatives for market expansion.
Bringing Experience to the Team
Dr. Schaefers joins Simtra with a rich background in leadership roles at notable companies such as LTS Lohmann Therapie-Systeme AG, Aenova Holding GmbH, and West Pharmaceutical Services. At LTS, he served as Chief Commercial Officer, where he successfully managed a global team that included members from Germany, the U.S., and China. His impressive career is marked by the development of strategies that have significantly boosted business growth, as well as overseeing collaborations, partnerships, and key acquisitions.
A Vision for Expansion
Franco Negron, CEO of Simtra BioPharma Solutions, stated, “Dr. Mike Schaefers brings a unique blend of strategic insights and operational know-how. His deep understanding of the complexities in our industry will be instrumental in enhancing our market presence and providing exceptional value to our clients.”
Dr. Schaefers Shares His Excitement
During this pivotal time of growth, Dr. Schaefers expressed his enthusiasm about becoming part of the Simtra team. “I am excited to join Simtra BioPharma Solutions at such a dynamic moment for the company,” he remarked. He looks forward to working alongside the talented team, building on the company’s achievements, and contributing to their mission of excellence within the CDMO landscape.
About Simtra BioPharma Solutions
Simtra BioPharma Solutions is a leading, independently owned Contract Development Manufacturing Organization with over 65 years of experience in sterile injectable manufacturing. The company is renowned for its exceptional cGMP sterile fill and finish capabilities, technical expertise, and a collaborative approach that empowers clients to meet their strategic goals.
Biotech and pharmaceutical companies frequently partner with Simtra to bring their molecules to market, whether by launching global innovations, refining formulations, or proactively addressing risks to enhance business growth.
Frequently Asked Questions
What position has Dr. Mike Schaefers been appointed to at Simtra?
Dr. Mike Schaefers has been appointed as Chief Commercial Officer and Head of Business Development.
What experience does Dr. Schaefers bring to the role?
Dr. Schaefers has extensive leadership experience from companies like LTS Lohmann Therapie-Systeme AG and West Pharmaceutical Services.
How does Simtra BioPharma Solutions support its clients?
Simtra collaborates with clients to launch innovations, improve formulations, and reduce risks associated with bringing products to market.
What are the core competencies of Simtra BioPharma Solutions?
Simtra is known for its cGMP sterile fill and finish, technical expertise, and high-quality service tailored to client needs.
Why is Dr. Schaefers excited about joining Simtra?
Dr. Schaefers is enthusiastic about the opportunity to contribute to Simtra's growth and success in the CDMO space.
